Richard Keefe

Affiliations: 
Duke Medical School, Durham, NC, United States 
Google:
"Richard Keefe"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Eskridge CLM, Hochberger WC, Kaseda ET, et al. (2021) Deficits in generalized cognitive ability, visual sensorimotor function, and inhibitory control represent discrete domains of neurobehavioral deficit in psychotic disorders. Schizophrenia Research. 236: 54-60
Turner TH, Atkins A, Keefe RSE. (2021) Virtual Reality Functional Capacity Assessment Tool (VRFCAT-SL) in Parkinson's Disease. Journal of Parkinson's Disease
Eum S, Hill SK, Alliey-Rodriguez N, et al. (2021) Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Keefe RSE. (2021) Where do we cut the bell-shaped curve of CIAS? Schizophrenia Research
Fleischhacker WW, Podhorna J, Gröschl M, et al. (2021) Efficacy and safety of the novel glycine transporter inhibitor BI 425809 once daily in patients with schizophrenia: a double-blind, randomised, placebo-controlled phase 2 study. The Lancet. Psychiatry. 8: 191-201
Seccomandi B, Agbedjro D, Bell M, et al. (2021) Exploring the role of age as a moderator of cognitive remediation for people with schizophrenia. Schizophrenia Research. 228: 29-35
Keefe RSE, Woods SW, Cannon TD, et al. (2020) A randomized Phase II trial evaluating efficacy, safety, and tolerability of oral BI 409306 in attenuated psychosis syndrome: Design and rationale. Early Intervention in Psychiatry
Kollins SH, DeLoss DJ, Cañadas E, et al. (2020) A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial. The Lancet. Digital Health. 2: e168-e178
Seccomandi B, Agbedjro D, Bell M, et al. (2020) Can IQ moderate the response to cognitive remediation in people with schizophrenia? Journal of Psychiatric Research. 133: 38-45
Cohen EA, Hassman HH, Ereshefsky L, et al. (2020) Placebo response mitigation with a participant-focused psychoeducational procedure: a randomized, single-blind, all placebo study in major depressive and psychotic disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
See more...